[HTML][HTML] Cannabidiol as a potential treatment for anxiety disorders

EM Blessing, MM Steenkamp, J Manzanares… - …, 2015 - Elsevier
Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum
drug that in recent years has drawn increasing interest as a treatment for a range of …

[HTML][HTML] Hippocampal GABAergic interneurons and memory

A Tzilivaki, JJ Tukker, N Maier, P Poirazi, RP Sammons… - Neuron, 2023 - cell.com
One of the most captivating questions in neuroscience revolves around the brain's ability to
efficiently and durably capture and store information. It must process continuous input from …

Hippocampal GABAergic inhibitory interneurons

KA Pelkey, R Chittajallu, MT Craig… - Physiological …, 2017 - journals.physiology.org
In the hippocampus GABAergic local circuit inhibitory interneurons represent only~ 10–15%
of the total neuronal population; however, their remarkable anatomical and physiological …

From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology

A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …

[HTML][HTML] CB1 receptor signaling in the brain: extracting specificity from ubiquity

A Busquets-Garcia, J Bains, G Marsicano - Neuropsychopharmacology, 2018 - nature.com
Endocannabinoids (eCBs) are amongst the most ubiquitous signaling molecules in the
nervous system. Over the past few decades, observations based on a large volume of work …

The cannabinoid system and pain

SG Woodhams, V Chapman, DP Finn, AG Hohmann… - …, 2017 - Elsevier
Chronic pain states are highly prevalent and yet poorly controlled by currently available
analgesics, representing an enormous clinical, societal, and economic burden. Existing pain …

The endocannabinoid system as a target for novel anxiolytic drugs

S Patel, MN Hill, JF Cheer, CT Wotjak… - … & Biobehavioral Reviews, 2017 - Elsevier
The endocannabinoid (eCB) system has attracted attention for its role in various behavioral
and brain functions, and as a therapeutic target in neuropsychiatric disease states, including …

[HTML][HTML] Presynaptic protein synthesis is required for long-term plasticity of GABA release

TJ Younts, HR Monday, B Dudok, ME Klein, BA Jordan… - Neuron, 2016 - cell.com
Long-term changes of neurotransmitter release are critical for proper brain function.
However, the molecular mechanisms underlying these changes are poorly understood …

[HTML][HTML] Cannabinoid control of learning and memory through HCN channels

M Maroso, GG Szabo, HK Kim, A Alexander, AD Bui… - Neuron, 2016 - cell.com
The mechanisms underlying the effects of cannabinoids on cognitive processes are not
understood. Here we show that cannabinoid type-1 receptors (CB1Rs) control hippocampal …

[HTML][HTML] Reviewing the role of the endocannabinoid system in the pathophysiology of depression

I Gallego-Landin, A Garcia-Baos… - Frontiers in …, 2021 - frontiersin.org
Major depressive disorder is a high-impact, debilitating disease and it is currently
considered the most prevalent mental illness. It is associated with disability, as well as …